# Nitric Oxide During CPB to Reduce AKI in Neonates

> **NCT03946462** · PHASE1 · WITHDRAWN · sponsor: **Fabio Savorgnan**

## Conditions studied

- Congenital Heart Disease
- Acute Kidney Injury

## Interventions

- **DRUG:** NO gas delivered during cardiac surgery
- **OTHER:** placebo gas delivered during cardiac surgery

## Key facts

- **NCT ID:** NCT03946462
- **Lead sponsor:** Fabio Savorgnan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-10
- **Primary completion:** 2022-10
- **Final completion:** 2023-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study could not be started because of some technical issues.
- **Last updated:** 2021-12-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03946462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03946462, "Nitric Oxide During CPB to Reduce AKI in Neonates". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT03946462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*